NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 17 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,000 | -56.4% | 155,000 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $39,000 | -15.2% | 155,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $46,000 | -20.7% | 155,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $58,000 | -42.0% | 155,000 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $100,000 | -3.8% | 155,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $104,000 | -64.9% | 155,000 | -52.3% | 0.00% | -66.7% |
Q1 2021 | $296,000 | +1641.2% | 325,000 | +1200.0% | 0.01% | – |
Q4 2020 | $17,000 | -5.6% | 25,000 | 0.0% | 0.00% | – |
Q3 2020 | $18,000 | -37.9% | 25,000 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $29,000 | +93.3% | 25,000 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | -6.2% | 25,000 | 0.0% | 0.00% | – |
Q4 2019 | $16,000 | +6.7% | 25,000 | 0.0% | 0.00% | – |
Q3 2019 | $15,000 | – | 25,000 | – | 0.00% | – |
Download |